Hi JD & Frog
Yes I did have the wrong figure for the optimised case. $53 + $25 = $78 not $88.
And my expansion figure was $40 + $25 = $65
where in both cases the $25 is the premium that 69% would attract above 62%. I understand that the premium would differ when 62% is $40 Vs $53 but probably not by too much.
There is a note d) in Table 5. attached to the "all in breakeven price" of 62% that says it is the break even of post construction cash flows. This I believe suggests it is calculated using opex and no capex.
So in the optimised case if the 62% price is $53 then MGT will be receiving revenue at $78/t. If that is a break even position it then means that the costs must be $78/t. In the expansion case if the 62% price is $40 then MGT will be receiving revenue at $65/t. If that is a break even position it then means that the costs must be $65/t.
So costs per t would be $78 for the optimised case and $65 for the expansion.
All figures quoted are US$
Have I got that right?
Baz
- Forums
- ASX - By Stock
- MGT
- Ann: Mines and Money Conference Presentation
MGT
magnetite mines limited.
Add to My Watchlist
2.56%
!
8.0¢

Ann: Mines and Money Conference Presentation, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.0¢ |
Change
0.002(2.56%) |
Mkt cap ! $9.681M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 7.9¢ | $21.75K | 272.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12258 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 1596 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12258 | 0.079 |
1 | 12500 | 0.078 |
1 | 64935 | 0.077 |
2 | 52473 | 0.076 |
3 | 240333 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 1596 | 1 |
0.082 | 57206 | 2 |
0.087 | 123555 | 1 |
0.090 | 44376 | 2 |
0.095 | 51200 | 2 |
Last trade - 15.47pm 27/06/2025 (20 minute delay) ? |
Featured News
MGT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online